Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study
CONCLUSION: UFT administration can improve the prognosis of EGFR mutation-negative LUAD but not EGFR mutation-positive LUAD. Thus, clinical trials of adjuvant-targeted therapy for EGFR mutation-positive stage IB LUAD should also be conducted in Japan.PMID:38105006 | DOI:10.5761/atcs.oa.23-00134
Source: Annals of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Masaya Aoki Ryo Miyata Go Kamimura Aya Harada Takeda Takayuki Suetsugu Keiko Mizuno Kazuhiro Ueda Source Type: research
More News: Adenocarcinoma | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Genetics | Heart | Japan Health | Study